Fizer Pharmaceutical paid $68 million on January 2, 2024, for 4 million shares of Carne Cosmetics common stock. The investment represents a 25% interest in the net assets of Carne and gave Fizer the ability to exercise significant influence over Carne’s operations. Fizer received dividends of $1 per share on December 21, 2024, and Carne reported net income of $40 million for the year ended December 31, 2024. The fair value of Carne’s common stock at December 31, 2024, was $18.50 per share.
∙ The book value of Carne’s net assets was $192 million.
∙ The fair value of Carne’s depreciable assets exceeded their book value by $32 million. These assets had an average remaining useful life of eight years.
∙ The remainder of the excess of the cost of the investment over the book value of net assets purchased was attributable to goodwill.

Required:
Prepare all appropriate journal entries related to the investment during 2024.